Company intelligence
Alpenglow Biosciences®
3D tissue imaging data for spatial biology
About Alpenglow Biosciences®
Alpenglow Biosciences accelerates drug development and improves clinical diagnostics with light-sheet 3D tissue imaging and AI-powered analysis for spatial biology and digital pathology. The Aurora 3D spatial biology platform digitizes intact tissue samples, delivering quantitative 3D datasets while preserving tissue for molecular analysis Partners use Alpenglow Biosciences to: - Discover new biology in intact tissue - Generate analysis-ready volumetric datasets and spatial metrics - Support AI model development with ground truth 3D data - Improve decision-making in preclinical and clinical programs Five of the top 10 pharmaceutical companies collaborate with Alpenglow to uncover new insights, streamline timelines, and improve success rates across their pipelines. We are hiring talented individuals for roles in business development, wet lab, hardware, and software.
Verified activity
Signals from Alpenglow Biosciences®
5 published signals
Research & Knowledge
Alpenglow Biosciences® is presenting a lunch symposium on 3D dermatopathology of inflammatory and neoplastic skin diseases at ESDR in Heidelberg.
Reported by Alpenglow Biosciences®
Research & Knowledge
Alpenglow Biosciences® participated in a survey to identify key issues in 3D Spatial Biology presented by Thomas Kroneis, PhD, Chair of the ESSB 3D Working Group.
Reported by Steve Pemberton
Presence & Recognition
Alpenglow Biosciences® is hosting a lunch event on September 10th featuring Dr. Sandra Schuh presenting her latest work using 3D imaging technologies.
Reported by Steve Pemberton
Research & Knowledge
Alpenglow Biosciences® published a study titled 'Delivery of a fibrin-binding hemostatic polymer ameliorates neurovascular damage and neural tissue loss after traumatic brain injury' using whole-brain 3D light-sheet imaging.
Reported by Alpenglow Biosciences®
Presence & Recognition
Alpenglow Biosciences® attended Dr. Sandra Schuh's lunch/lecture at ESDR
Reported by Steve Pemberton